Navigation Links
REMOXY(R) NDA Filing Accepted by FDA and Priority Review Granted
Date:8/12/2008

CUPERTINO, Calif., Aug. 12 /PRNewswire-FirstCall/ -- DURECT Corporation (Nasdaq: DRRX) announced today that the US Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) of REMOXY(R) and granted Priority Review. The FDA typically grants Priority Review to drug candidates that have the potential to demonstrate significant improvements compared to marketed products. The FDA goal for completing review of a drug with Priority Review status is six months from the date the application was submitted. The REMOXY NDA was submitted to the FDA by Pain Therapeutics on June 10, 2008.

(Logo: http://www.newscom.com/cgi-bin/prnh/20020717/DRRXLOGO)

"We are pleased that the NDA has been accepted and that REMOXY will receive Priority Review," stated James E. Brown, DVM, President and CEO of DURECT. "The abuse of pain medications is a widespread problem in this country and addressing that issue is clearly in the public interest. We're delighted that our ORADUR(TM) technology has enabled the development of REMOXY, an investigational drug that has the potential to be the first oxycodone on the market that deters common methods of abuse."

REMOXY is being developed by Pain Therapeutics (Nasdaq: PTIE) under license from DURECT, and Pain Therapeutics has, in turn, sublicensed the commercialization rights for this drug candidate to King Pharmaceuticals (NYSE:

SOURCE DURECT Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Lixte Biotechnology Holdings Announces Filing of a New Patent Application for the Use of Novel Compounds as Potential Treatment for Neurodegenerative Diseases
2. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
3. Embryo Viability Studies Support Utility of Novel, Metabolomic Profiling Technology
4. ISTA Pharmaceuticals Announces New Phase III Clinical Findings to Support Bepreve NDA Filing
5. Preclinical Study Shows CTIs Brostallicins Cancer-Killing Ability Based on Genetic Profiling
6. Oncology Drug Development Update - Molecular Profiling Redefines the Nature of Malignancy and Increases the Adoption of Targeted Therapeutics
7. Watson Announces Silodosin NDA Accepted for Filing by FDA for the Treatment of Benign Prostatic Hyperplasia
8. Imaging Diagnostic Systems Updates PMA Filing Status for the New CT Laser Breast Imaging System
9. Schering-Plough Announces Asenapine NDA Accepted for Filing by the U.S. FDA
10. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
11. Wyeth Presents New Phase 3 Data and Updates Regulatory Timing for NDA Filing of Bazedoxifene/Conjugated Estrogens

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...YORK, Dec. 1 Reportlinker.com anno...le in its catalogue: ,, HPLC Systems & Acc...w.reportlinker.com/p0164366/HPLC-Systems--Accessor...ears, Liquid Chromatography has emerged as a workh... food and beverage, research and development, and ...
(Date:12/1/2009)...EVUE, Wash., Dec. 1 drug... retailer of health, beauty, vision, and pharmacy ...s best day ever as customer orders were the highes...gstore.com and Beauty.com web stores featured m...r largest gift selection yet. ,, (Logo: http:/...
(Date:12/1/2009)...ORK, Dec. 1 Reportlinker.com annou...e in its catalogue: ,, Molecular Diagnostics -...nker.com/p0164231/Molecular-Diagnostics---A-World-...rket is being driven by several growth factors tha...e techniques, which combine optimized sample prepa...
Breaking Medicine Technology:Reportlinker Adds HPLC Systems & Accessories - A World Market Review 2Reportlinker Adds HPLC Systems & Accessories - A World Market Review 3Reportlinker Adds HPLC Systems & Accessories - A World Market Review 4Reportlinker Adds HPLC Systems & Accessories - A World Market Review 5Reportlinker Adds HPLC Systems & Accessories - A World Market Review 6Reportlinker Adds HPLC Systems & Accessories - A World Market Review 7drugstore.com, inc. Has Best Day Ever on Cyber Monday 2drugstore.com, inc. Has Best Day Ever on Cyber Monday 3Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7Scholar unconvinced new lie detection methods better than old ones 8689 1Scholar unconvinced new lie detection methods better than old ones 8689 2Scholar unconvinced new lie detection methods better than old ones 8689 3Scholar unconvinced new lie detection methods better than old ones 8689 4ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 1ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 2ClearTrial to Chair Session at DIA 45th Annual Meeting on 26quot 3BEffective Operational Planning for Adaptive Clinical Trials 26quot 3B 12415 3Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 1Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 2Kashi Company Debuts Heart to Heart 28TM 29 Whole Grain Crackers 47606 3
...c. 12 According to data,released by the National ...holesterol levels would be more likely to consider...an a prescription (Rx) product, but,the likelihood...ngs of the,survey are being made public on the eve...ation Advisory Committees. At that meeting, member...
...n Calls on Hospitals to Invest More Resources and ... WASHINGTON, Dec. 11 U.S. healthcare,facilities a...illin-resistant Staphylococcus aureus (MRSA) infec...l professionals released today., The online poll ...Infection Control (APIC) found that 59 percent of ...
Other Medicine Technology:Survey Finds At-Risk Consumers Interested in OTC Statin 2Survey Finds At-Risk Consumers Interested in OTC Statin 3Survey Finds At-Risk Consumers Interested in OTC Statin 4Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA 2Survey Finds U.S. Healthcare Facilities Not Doing Enough to Curb MRSA 3
(Date:12/2/2009)... Highlights Dangers ,, WASHINGTON, Dec. 2 /...ps have their way, many medical treatments and pre...r threat. The pressure that the US bishops have b...m has been widely reported. An ad in this morning,...that pressure to influence healthcare policy is no...
(Date:12/2/2009)...at affects male urethra, researchers say , ...bies of women who use insect repellents during the...ncreased risk for a birth defect called hypospadia...ch affects about two of every 500 male infants, in...be that carries urine from the bladder to the open...
(Date:12/2/2009)...in the battle against drug abuse, but new research...y dozens of human disease could claim that role. ...sed as a simpler and more convenient animal model ...s of abuse on the brain. Their study appears onlin...urnal. , Andrew Ewing and colleagues note that ...
(Date:12/2/2009)...leading vendor of Internet-based chronic disease m...n of its software offering. The new release now i... weight management capabilities in addition to the... Acton, MA. (PRWEB) December 2, ...rnet-based chronic disease management software, ha...
(Date:12/2/2009)...rt of the Hewlett-Packard Company,s Create Change ...ewswire/ -- The Hewlett-Packard Company Foundation... help fund American Red Cross disaster response. ...20090108/RedCrossLOGO ) ,, The largest contrib...unities affected by typhoons in September and Octo...
Breaking Medicine News(10 mins):Health News:Everybody's Healthcare Is Threatened by Catholic Bishops' Interference 2Health News:MyCareTeam™ Significantly Extends Diabetes Offering to Include Management of Hypertension, Obesity, and Congestive Heart Failure 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 2Health News:Hewlett-Packard Company Foundation Donates $1 Million for Red Cross Disaster Response 3
...han any other joint, in part because of their intr...prone to knee problems, and they injure the// ante.... Knees & Hips: A Troubleshooting Guide to Knee an...also outlines steps women can take to reduce their...
...d by USC School of Dentistry researcher Songtao Sh...ot and supporting// periodontal ligaments to resto...ough holds significant promise for clinical applic...ed wisdom teeth of 18- to 20-year olds, Shi and co...
...deposits in brain seen in people with Alzheimer's ...rom this disorder suffer mostly in their cognitive...new scanning technique might be able to distinguis...imated to suffer from this incapacitating disorder...
...kseat passengers risk injury or death to themselve...ent of a head-on crash.// Automobile sled test...and using crash-test dummies have demonstrated the...he risk of severe injury was not evident during sl...
...rganisation (ILO) and industry lobbies, several hu...tion at workplace to prevent spread// of HIV infec...environment. "Impact of HIV/AIDS is seen mos...eration of Indian Industry (CII) here Wednesday. ...
... issue of the medical journal Otolaryngology- Head...ng protection for soldiers to// prevent permanent ...ure to the sound of gunshots. The study mea... to the impulse noise generated by five gunshots f...
Other Medicine News:Health News:Researchers Use Stem Cells to Regenerate Parts of Teeth 2Health News:Novel Brain Scan to Diagnose Alzheimer's Disease 2Health News:Novel Brain Scan to Diagnose Alzheimer's Disease 3Health News:Unbelted Backseat Passengers Produce Deadly Results 2Health News:Corporate Inc Awakening To Economic Impact Of HIV 2Health News:Corporate Inc Awakening To Economic Impact Of HIV 3
12 Frame Locking Rod Display
... provides maximum impact for the marketing of opti...isplaying frames allows your retail area to maximi... and eye-catching displays. The products are shown...movable holders. Variable number of frames display...
Eye Vee 2.0 Clip
Clinical DataBase
Medicine Products: